Drug developer Protox Therapeutics posts net loss of $2.4 million in Q4
VANCOUVER – Drug developer Protox Therapeutics Inc. (TSX:PRX) reports net loss of $2.4 million for the fourth quarter compared with a loss of $1.5
View full post on Gold Silver News RSS Feed – Silver News
$2.4, developer, Drug, Loss, million+, Posts, Protox, Therapeutics
RSS Site Feed